Biosimilars
Imminent infringement at the core of Novartis' UPC claim against Celltrion
Yesterday, the Düsseldorf local division heard the dispute between Novartis and Celltrion. At the heart of the case was the fundamental question of th
...
1 August 2024 by Konstanze Richter